about
Omega-3 fatty acids: potential role in the management of early Alzheimer's diseaseToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseTHE ROLE OF CYSTEINE PROTEASE IN ALZHEIMER DISEASEPerception of Alzheimer Disease in Iranian Traditional MedicineAdvances in development of fluorescent probes for detecting amyloid-β aggregatesExposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysisPhysical restraint use and falls in nursing homes: a comparison between residents with and without dementiaThe Alzheimer's disease neuroimaging initiative: progress report and future plansCommon variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status.Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.A review of cardiorespiratory fitness-related neuroplasticity in the aging brain.Thyroid hormones are associated with longitudinal cognitive change in an urban adult population.RNA aptamers generated against oligomeric Abeta40 recognize common amyloid aptatopes with low specificity but high sensitivityThe PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriersHospitalization in community-dwelling persons with Alzheimer's disease: frequency and causes.Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in CanadaIdentification of beta-secretase (BACE1) substrates using quantitative proteomics.Quantitative pharmacology approach in Alzheimer's disease: efficacy modeling of early clinical data to predict clinical outcome of tesofensine.Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo.A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's diseaseKnowledge of Alzheimer's disease, feelings of shame, and awareness of services among Korean American elders.Boosting power for clinical trials using classifiers based on multiple biomarkers.D10S1423 identifies a susceptibility locus for Alzheimer's disease (AD7) in a prospective, longitudinal, double-blind study of asymptomatic individuals: results at 14 years.Current treatment and recent clinical research in Alzheimer's diseaseBeyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implicationsOne-carbon metabolism and Alzheimer's disease: focus on epigeneticsEstimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directionsGenetic variation and neuroimaging measures in Alzheimer disease.Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease.Video-based coping skills to reduce health risk and improve psychological and physical well-being in Alzheimer's disease family caregivers.Late-life depression with comorbid cognitive impairment and disability: nonpharmacological interventions.Caregivers in China: knowledge of mild cognitive impairment.Report of the task force on designing clinical trials in early (predementia) AD.Treatment of sleep disturbance in Alzheimer's dementia.ER calcium and Alzheimer's disease: in a state of flux.Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.Transcranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease
P2860
Q24595490-80961C7C-3F48-4286-B3E9-BAE7FB996BB6Q24595802-09E431DB-7A0B-4CC0-9DA9-446D445EF5E3Q26740104-3880082C-70CF-4514-BAD2-434E1D8F9842Q26744267-324EE307-8D8E-41F7-A2C7-CE0DFA4A4C27Q26753175-810807FA-D5E5-4995-B47F-A9806F2EF541Q26998413-C96B7854-838A-4BE8-8E39-61BDFF15E50CQ28304379-0D63FCAF-398F-4CD7-819F-31D6ABC23E95Q28749585-F38E64FF-5C12-4CF5-BDB5-F4826112664CQ28943325-30FCDEF0-99E6-4F4C-A208-207DF7333C06Q30471693-E49D5FE9-11F4-411C-932A-CAAB47DC3D1EQ30498720-A2C00064-830B-476E-9D93-645D280795A5Q30656552-023E68FC-5319-4159-A6CC-61D43F995131Q30668962-0A07B4CF-8946-4CD9-9B78-69AFAE30583CQ30879431-C33A5049-57AF-4C47-919B-30452CB9EC47Q31129910-717D2505-6277-4A47-B749-052132AB810BQ33158873-7307E40D-1409-45AF-892B-0D7A7C79F967Q33521121-B849B8AA-2AED-44CA-8D8D-846DC0C1419BQ33521280-320F6110-F5BF-490A-9DD7-13AE87D55DE4Q33524423-B09EFBFA-3514-4037-B8A9-0C9C6CB77DC1Q33773031-4446B2D1-332F-4E55-953E-20F5E075283CQ33793579-A46AC78B-7B1A-4B89-9EEF-15E46EDF4378Q33896054-CFCD27D3-4410-439C-AAD8-02549E9A09C3Q33902517-806A0F96-0635-49C0-97E6-46476860D5BAQ33990250-E4FD7559-F799-43B0-9E09-6033E25CB338Q34019444-F8374F41-CACE-4E15-832E-1098EB147610Q34067487-5FD052B3-0B3C-490F-88F7-ED4897E25E15Q34069264-6DA0B556-56EB-489B-8404-7E808DDFFA39Q34094250-44936B92-2B38-43B4-A301-6D4E1016D84AQ34135724-6C01E265-1BFD-4C96-B960-848C53A96662Q34208735-25B17C23-119C-4692-AC7D-211C7D27D0B0Q34245127-9555CF60-D243-4C22-A0D3-18425D52F6DAQ34421108-5D781E7E-57E1-468A-90AA-A811536D80ACQ34440080-AFEE68F5-50DA-4EB4-B97D-B99631B697CDQ34551959-6027BACD-EABC-49F0-8235-EB86E79F955BQ34555301-118B180C-1FA7-4C7F-83B6-C348F3153C46Q34623833-616B797A-9338-4FD3-A8AF-4E2FEC60DCF6Q34966217-1F3B88A6-7E13-45EF-90BE-2FC31AB735DBQ34991223-DC9250EC-7980-4C90-98A1-0122E15EE9E7Q35027999-DFE851DE-EC95-4AF5-A505-68F580CB330EQ35050916-9770D283-DD81-40D3-A1B9-E42E5659F201
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
2009 Alzheimer's disease facts and figures.
@en
2009 Alzheimer's disease facts and figures.
@nl
type
label
2009 Alzheimer's disease facts and figures.
@en
2009 Alzheimer's disease facts and figures.
@nl
prefLabel
2009 Alzheimer's disease facts and figures.
@en
2009 Alzheimer's disease facts and figures.
@nl
P1476
2009 Alzheimer's disease facts and figures.
@en
P2093
Alzheimer's Association
P304
P356
10.1016/J.JALZ.2009.03.001
P577
2009-05-01T00:00:00Z